This site is no longer being updated. Data are accurate as of 2 Dec 2022.

GeneOne Life Science, Inc.: GLS-5310

GeneOne Life Science, Inc.: GLS-5310

Vaccine Type: DNA

About Trial Phases

Phase 1: 3 Trials

NCT04673149
Republic of Korea
NCT05085639
Puerto Rico
NCT05182567
Puerto Rico

Phase 2: 1 Trial

NCT04673149
Republic of Korea

Phase 3: 0 Trials

There are no trials for this phase.

Approvals

This vaccine is not yet approved.

Registered Trials

NCT04673149
Phase 1/2
Republic of Korea
Total Enrollment: 345
Official Trial Registration:
- NCT04673149(Opens in new tab/window)
NCT05085639
Phase 1
Puerto Rico
Total Enrollment: 30
Official Trial Registration:
- NCT05085639(Opens in new tab/window)
NCT05182567
Phase 1
Puerto Rico
Total Enrollment: 72
Official Trial Registration:
- NCT05182567(Opens in new tab/window)

© 2023 VIPER Group COVID19 Vaccine Tracker Team

Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)

This site is provided for informational purposes only based on publically available data.

Site Credits Website Feedback Form